Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
Stock Information for Qualigen Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.